Liu YT - Search Results

1

How to choose a point-of-care testing for troponin.

Lin YH, Zhang Y, Liu YT, Cui K, Kang JS, Zhou Z. Lin YH, et al. Among authors: liu yt. J Clin Lab Anal. 2020 Jul;34(7):e23263. doi: 10.1002/jcla.23263. Epub 2020 Mar 28. J Clin Lab Anal. 2020. PMID: 32222055 Free PMC article.

2

Autoantibody profiling identifies predictive biomarkers of response to anti-PD1 therapy in cancer patients.

Tan Q, Wang D, Yang J, Xing P, Yang S, Li Y, Qin Y, He X, Liu Y, Zhou S, Duan H, Liang T, Wang H, Wang Y, Jiang S, Zhao F, Zhong Q, Zhou Y, Wang S, Dai J, Yao J, Wu D, Zhang Z, Sun Y, Han X, Yu X, Shi Y. Tan Q, et al. Theranostics. 2020 May 16;10(14):6399-6410. doi: 10.7150/thno.45816. eCollection 2020. Theranostics. 2020. PMID: 32483460 Free PMC article.

3

[Classification and regression tree analysis of clinical patterns to predict the survival of patients with advanced non-small cell lung cancer treated with erlotinib].

Liu Y, Guo J, Wang Y, Yang J, Wang Z. Liu Y, et al. Zhongguo Fei Ai Za Zhi. 2011 Oct;14(10):785-9. doi: 10.3779/j.issn.1009-3419.2011.10.04. Zhongguo Fei Ai Za Zhi. 2011. PMID: 22008108 Free PMC article. Chinese.

4

[Classification and regression tree analysis of 154 patients with cancer of unknown primary].

Wang ZP, Liu YT, Yang J. Wang ZP, et al. Among authors: liu yt. Zhonghua Zhong Liu Za Zhi. 2010 Sep;32(9):690-3. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 21122385 Chinese.

5

Prognostic significance of molecular characteristics of cerebrospinal fluid for non-small cell lung cancer patients with leptomeningeal metastasis.

Li N, Liu Y, Duan J, Yang B, Bai H, Sun R, Yu L, Wang J. Li N, et al. Thorac Cancer. 2019 Aug;10(8):1673-1682. doi: 10.1111/1759-7714.13123. Epub 2019 Jul 10. Thorac Cancer. 2019. PMID: 31368671 Free PMC article.

6

Survival and pretreatment prognostic factors for extensive-stage small cell lung cancer: A comprehensive analysis of 358 patients.

Huang LL, Hu XS, Wang Y, Li JL, Wang HY, Liu P, Xu JP, He XH, Hao XZ, Jiang PD, Liu YT, Luo J, Zhou SY, Wang JW, Yang JL, Qin Y, Yuan P, Lin L, Shi YK. Huang LL, et al. Among authors: liu p, liu yt. Thorac Cancer. 2021 Jul;12(13):1943-1951. doi: 10.1111/1759-7714.13977. Epub 2021 May 9. Thorac Cancer. 2021. PMID: 33969619 Free PMC article.

7

Metastatic NSCLCs With Limited Tissues: How to Effectively Identify Driver Alterations to Guide Targeted Therapy in Chinese Patients.

Li W, Li Y, Guo L, Liu Y, Yang L, Ying J. Li W, et al. JTO Clin Res Rep. 2021 Mar 24;2(5):100167. doi: 10.1016/j.jtocrr.2021.100167. eCollection 2021 May. JTO Clin Res Rep. 2021. PMID: 34590019 Free PMC article.

8

[Classification and regression tree analysis of clinical patterns that predict survival in 127 Chinese patients with advanced non-small cell lung cancer treated by gefitinib who failed to previous chemotherapy].

Wang Z, Guo J, Wang Y, Liu Y, Yang J. Wang Z, et al. Zhongguo Fei Ai Za Zhi. 2011 Sep;14(9):699-703. doi: 10.3779/j.issn.1009-3419.2011.09.04. Zhongguo Fei Ai Za Zhi. 2011. PMID: 21924034 Free PMC article. Chinese.

9

Clinicopathologic characteristics and outcome of patients with different EGFR mutations.

Zhou S, Hu X, Wang Y, Li J, Zhou L, Hao X, Liu Y, Shi Y. Zhou S, et al. Asia Pac J Clin Oncol. 2019 Jun;15(3):166-171. doi: 10.1111/ajco.13072. Epub 2018 Oct 11. Asia Pac J Clin Oncol. 2019. PMID: 30311393

10

Rechallenge pemetrexed-based chemotherapy provides an option for initially benefited patients with advanced lung adenocarcinoma.

Wang JN, Qiao QH, Hu XS, Liu YT, Wang ZJ, Duan JC, Feng Y, Zhu HH. Wang JN, et al. Among authors: liu yt. Chin Med J (Engl). 2021 Jun 16;134(17):2119-2121. doi: 10.1097/CM9.0000000000001511. Chin Med J (Engl). 2021. PMID: 34133351 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,257 results

Search Page